Notably, GLP-1R is abundantly expressed in various brain regions, including the hypothalamus, cortex, and hippocampus, as well as peripheral nervous tissues [10]
Melanotan is reported to reduce appetite, which could lead to weight loss, but this is only a side effect of this peptide
User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses
Meanwhile, Aon reports that prescription drug costs comprise about one-third of employers overall healthcare spend, expected to spike about 9.5% this year